Posts in News Coverage
Pain Medicine News: FDA Approves ‘Low-Dose,’ Recharge-Free Neurostimulation System

The FDA approved the recharge-free neurostimulation system (Proclaim XR, Abbott) for the treatment of chronic pain. The Proclaim XR platform delivers a low dose of Abbott’s proprietary BurstDR stimulation waveform, which was created “to mimic natural patterns found in the brain,” according to a press release from Abbott. The system delivers mild electrical pulses to change pain signals as they travel from the spinal cord to the brain.

Read More
News CoveragePatientEdge